A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma
Clinical trial NCT02609230 · COMPLETED
Trial details
- NCT number
- NCT02609230
- Sponsor
- Fox Chase Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-05
- Primary completion
- 2020-03-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.